Finance

Beta
Lists
SPRB:NASDAQ
Spruce Biosciences, Inc
$54.70
+4.47%
(+2.34) 1D
$51.64
-5.59% (-3.06)
After hours
Closed: Jun 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPRB...
Open
$52.05
High
$55.95
Low
$52.00
Mkt. cap
150.55M
Avg. vol.
55.06K
Volume
96.38K
52-wk high
$240.00
52-wk low
$7.26
EPS
-$38.31
Beta
3.12
Shares outstanding
2.75M
No. of employees
14
Open
$52.05
High
$55.95
Low
$52.00
Mkt. cap
150.55M
Avg. vol.
55.06K
Volume
96.38K
52-wk high
$240.00
52-wk low
$7.26
EPS
-$38.31
Beta
3.12
Shares outstanding
2.75M
No. of employees
14
News stories
From sources across the web
About Spruce Biosciences, Inc
CEO-
Employees14
Founded2014
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitesprucebio.com
Analyst Ratings
Based on 7 analysts giving stock ratings to SPRB in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for SPRB in the last 3 months.
Highest
Current $54.70
$230.00 (+320.48%)
Average
$149.71 (+173.69%)
Lowest
$120.00 (+119.38%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Debjit Chattopadhyay
Guggenheim
Buy
Initiated
$123.00
+124.9%
06/16/2026
Catherine Novack
JonesTrading
Buy
Initiated
$135.00
+146.8%
06/08/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$150.00
+174.2%
06/01/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$230.00
+320.5%
05/27/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
$120.00
+119.4%
05/15/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$150.00
+174.2%
05/14/2026
Albert Lowe
Craig-Hallum
Buy
Initiated
$140.00
+155.9%
04/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-430.00K
5.01M
-1.80M
7.58M
Cost of revenue
-430.00K
5.01M
-1.80M
7.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.12M
3.22M
5.00M
4.41M
Operating expense
3.12M
3.22M
5.00M
4.41M
Total operating expenses
2.69M
8.23M
3.20M
11.99M
Operating income
-2.69M
-8.23M
-3.20M
-11.99M
Other non operating income
-
-
-3.50M
-91.00K
EBT including unusual items
-2.07M
-8.21M
-14.65M
-12.27M
EBT excluding unusual items
-2.07M
-8.21M
-6.75M
-12.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.07M
-8.21M
-14.65M
-12.27M
Net profit margin
-
-
-
-
Earnings per share
-
-14.58
-9.58
-8.94
Interest and investment income
654.00K
36.00K
-
486.00K
Interest expense
-29.00K
-19.00K
-46.00K
-674.00K
Net interest expenses
625.00K
17.00K
-46.00K
-188.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.68M
-8.23M
-3.20M
-11.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer